Navigation Links
Watson First Quarter 2011 Net Revenue Increases to $877 Million
Date:4/27/2011

rted net income to adjusted EBITDA for the three months ended March 31, 2011 and 2010:

Table 5Adjusted EBITDA Reconciliation Table(Unaudited; in millions)Three Months Ended
March 31,20112010GAAP net income

$
45.3$
9.8Plus:Interest expense

21.820.3Interest income

(0.8)(0.4)Provision for income taxes

41.336.7Depreciation (includes accelerated depreciation)

23.024.7Amortization(1)

57.139.0EBITDA187.7190.1Adjusted for:Global supply chain initiative (2)

6.53.8Acquisition and licensing charges (3)

4.619.4Non-cash impairment charges (4)

14.41.0Other (gains) losses (5)

(5.7)(23.4)Legal settlements (6)

-3.0Share-based compensation (7)

8.45.0Adjusted EBITDA

$
215.9$
98.9Notes:1. Amortization of acquired intangible assets, such as product rights, core technology and customer relationships, and amortization related to equity method investments recorded in other income (expense).  

2. The global supply chain initiative relates to closing or restructuring operations to gain efficiencies and operational excellence. The types of expenses include employee separation costs, product transfer expenses and accelerated depreciation.

3. Acquisition and licensing include upfront payments for products under development and fair market adjustments related to contingent obligations.

4. Non-cash impairment charges recorded to write-down tangible or intangible assets to fair value.

5. Other (gains) losses are excluded from non-GAAP results.

6. Legal settlements include amount associated with significant matters not related to current operations.

7. Share-based compensation relates to a non-cash accounting expense resulting from the issuance of restricted stock or stock options to employees and directors. The following table presents a reconciliati
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. New Life Agency Adds Watson to Join Walgreens on The Fertility Pharmacy Care Card for Fertility Medication
2. Watson Confirms Welchol® Patent Challenge
3. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
4. Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings
5. Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia
6. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
7. Watson Confirms OxyContin® Patent Challenge
8. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
9. Cephalon Wins FENTORA Patent Suit Against Watson
10. Watson Launches Generic Famvir®
11. Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Moerae Matrix, ... novel therapeutics that target inflammation and fibrosis, today ... M.D., PhD, as Chief Medical Officer. ... development strategy and programs, which include a pipeline ... and fibrotic conditions.  Bill is an accomplished strategist ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... SUNNYVALE, Calif. , July 6, 2015   ... will report financial results for its 2015 second quarter ... after the close of the market. The ... Pacific Time on Thursday, July 23, 2015, to discuss ... Cepheid,s website at http://ir.cepheid.com at least 15 ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... Calif., March 1, 2012 A consistent theme ... relationship, technological innovation and disease treatment is progression.  ... be seen in healthcare IT, which is expected ... to the healthcare industry.  Companies must maintain a ...
... 1, 2012  In a single bound, Nepean Cancer Care ... for its prostate cancer cases to a dramatically faster ... a technique that is even quicker with Elekta,s new ... treated their first patient with prostate cancer using Integrity ...
Cached Medicine Technology:Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 2Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 3Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System 2Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System 3
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community program in the Livonia, ... Youth and announced a new charity campaign to raise funds in support of the ... abuse. Livonia Save Our Youth is a coalition created especially to educate and empower ...
(Date:7/6/2015)... ... July 06, 2015 , ... World renowned Los Angeles facial ... their ideal appearance through comprehensive treatment solutions. Individuals that want to make multiple changes ... receive a plan that resolves each of their needs. , "Anytime I see ...
(Date:7/6/2015)... Florida (PRWEB) , ... July 06, 2015 , ... ... solutions, announced today that Randstad Technologies selected Aspect Software Unified IP contact center ... the United States, selected Aspect Unified IP as its future call center platform. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us and ... million Americans have diabetes, the majority of which are Type 2. However, eight million ... than one in three, have prediabetes (abnormally high blood sugar levels). Without reductions in ...
(Date:7/6/2015)... ... ... The Path of Least Resistance: The Evolution of Capitalism and Politics in ... over the past 40 years. The book explores the evolution of the global economy ... a time capsule that chronicles the economic development of the United States — from ...
Breaking Medicine News(10 mins):Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2
... , , OMAHA, Neb., Aug. ... equity sponsor, Diamond Castle Holdings and the Company,s Management Team have ... renegotiated favorable new terms and conditions with its banking partners. The ... a result of this transaction, overall debt for YORK Label is ...
... WASHINGTON, Aug. 24 In response to "Dietary ... H ealth: A Scienti f ic State m ent From the American Heart Association," publi ... Circulat i on, Dr. Maureen Storey, senior vice president ... h e America n Beverage A ssociation, said: , , ...
... , VA and DoD systems must be ... LOUISVILLE, Ky., Aug. 24 The American Legion is calling ... of Veterans Affairs (VA) and the Department of Defense (DoD). , ... Committee (NEC), the nation,s largest veterans service organization strongly reiterated its longstanding ...
... , Proposed Medicare Cuts Will Harm ... Staff Jobs in Jeopardy , , Study Finds ... SACRAMENTO, Calif., Aug. 24 A new American Health Care ... impact of a recently-enacted Medicare regulation cutting Medicare-funded nursing home care by ...
... male hormone boosted cardiac performance in Italian study ... of the male hormone testosterone increased blood-pumping ability ... failure, Italian researchers report. , "From our study, ... both patients with low and normal testosterone levels, ...
... RESEARCH TRIANGLE PARK, N.C., Aug. 24 GlaxoSmithKline ... of Advair Diskus(R) (fluticasone propionate and salmeterol inhalation powder) medication ... near Richmond, Virginia. Medicine in the stolen cartons could ... the legitimate supply chain and the storage conditions under which ...
Cached Medicine News:Health News:YORK Label Announces Continued Investment in the Company 2Health News:American Beverage Association Response to American Heart Association Statement on Added Sugars 2Health News:The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 2Health News:New Study of House Health Reform Bill: California Faces Over $3.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years 2Health News:Testosterone Therapy May Help Men With Heart Failure 2Health News:Testosterone Therapy May Help Men With Heart Failure 3Health News:GSK Advisory: Warehouse Theft 2
... Microscope with excellent maneuverability. Konan ... weight maintaining high quality. Easy ... by simply changing the adapter. ... has resulted in a sharp ...
... The Optimal temporary implant for use with ... The pupil dilator type 5S is a ... of the pupil during phacoemulsification. It is ... use. Indication: Expansion of the pupil during ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... anatomy of the eyelid for maximum patient ... ease of insertion. Easily removal with forceps. ... offer a slightly smaller bulb for easier ... the same clear and polished silicone as ...
Medicine Products: